Menu
Menu
Menu
Visiting Professor in the Division of Surgery within the Department of Surgery and Cancer, Imperial College London, Pat Price is an academic clinical oncologist specialising in PET based molecular imaging, advanced radiotherapy techniques and translational research in oncology.
She pioneered the use of PET molecular imaging for micro-dosing pharmacokinetic and pharmacokinetic studies of new cancer agents and has one of the best insights into the potential of the application of this technology for oncology drug development.
Professor Price is the co-editor of the standard UK oncology textbook ‘Treatment of Cancer’, now in its 7th edition. She was President of the British Oncological Association from 2002 to 2004 and was a member of the 2008 UK Research Assessment Exercise oncology subcommittee.
A recognised opinion leader in PET based molecular imaging in cancer and advanced radiotherapy, she was profiled in Cancer World: Pat Price: asking the right questions.
Sarah has worked in the voluntary sector since 2009 and was appointed Charity Director of Radiotherapy UK in 2022. Sarah has experience in charity development, frontline delivery, fundraising and advocating for change. She has a strong record of leading charities that punch above their weight. Her contribution to the community was recognised in the award of MBE in June 2018. Sarah’s focus is to lead Radiotherapy UK into the next stage of its development, increasing support for radiotherapy services throughout the UK and amplifying the voices of the radiotherapy patients and workforce.
Lynsey is a Therapeutic Radiographer with over 25 years experience in both in the NHS and private sectors. Lynsey has excelled in many roles within radiotherapy, Clinical Specialist in radiotherapy treatment, Research and Development Lead, Radiotherapy Deputy Manager to name a few. Lynsey has presented her research at academic conferences in the UK and abroad and has set up clinical trials from concept to approvals through to recruitment and follow up. She has volunteered for RTUK for over 10 years during her clinical career and was instrumental in setting up the Champions Network. She has also raised much needed funds for the charity doing various organised running events. Lynsey now works for the charity as an adviser and expert in the field of radiotherapy.
Dr Christy Goldsmith is a Clinical Oncologist specialising in an advanced radiotherapy technique called Stereotactic Body Radiotherapy (SBRT). She is a Committee Member on the SABR Consortium UK, a Consortium which has been active in advocating for access for patients to SBRT treatment, as well as developing treatment guidelines, and furthering UK SBRT research.
Dr Goldsmith has presented Internationally at Radiotherapy meetings (ASTRO/ESTRO/RSS) on outcomes of UK SBRT. She has also ran the British 10k London to fundraise for Radiotherapy UK.
Dr. Clive Harmer was consultant in Clinical Oncology and head of the Thyroid Unit at the Royal Marsden Hospital, London. As a medico-legal expert witness he specialises in breach of duty and causation covering a broad spectrum of different malignancies. He is co-editor of “Practical Management of Thyroid Cancer” – second edition to be published in 2018, and has over 200 peer-reviewed publications with the majority on thyroid disease. Clive is also patron of the Butterfly Thyroid Cancer Trust, and council member of the Medical Society of London.
Professor Philip Mayles graduated from Gonville and Caius College, Cambridge in 1968 and completed a master of science degree in radiation physics at St Bartholemew’s Hospital Medical School. In 1986, he obtained a PhD from the Faculty of Medicine in London University, and was appointed head of clinical radiotherapy physics at the Royal Marsden Hospital. In 1994, he moved to Clatterbridge Centre for Oncology as head of the Physics Department.
Professor Philip Mayles became chairman of the Radiotherapy Topic Group of the Institute of Physics and Engineering in Medicine. He has an active interest in research especially in improving the physical basis of radiotherapy treatment and treatment planning.
Dr Nighat Awan OBE, CEO of the Shere Khan Group as a Radiotherapy UK Ambassador. Dr Awan is an internationally celebrated business leader, who is passionate about our work to improve access to world-class radiotherapy for every person, no matter where they live, in the UK. As a cancer survivor herself she has a special connection with the charity.
Tim Farron MP is currently the Member of Parliament for Westmoreland and Lonsdale, having been elected in his constituency since 2005. Tim has campaigned extensively for a radiotherapy unit in Westmorland General Hospital. He has previously arranged a radiotherapy reception in parliament, meeting with experts from across Britain to shine a light on radiotherapy and the benefits that it can bring to patients and in improving cancer outcomes.
Subsequently, the Access to Radiotherapy Bill 2017 – 19 was established to make provision to improve access to radiotherapy treatment in England; Tim has worked closely with Radiotherapy UK and supports our missions.
Brian Robson, OBE, was an English football manager and a former player. He represented England on 90 occasions between 1980 and 1991. On 16 March 2011, it was revealed that he had been diagnosed with throat cancer and treated with surgery and radiotherapy.
“I am delighted to support the vital work of Radiotherapy UK. Radiotherapy helped to save my life, it is so important that everyone who needs it has access to the best treatment available. Radiotherapy UK has its foundations in the science and research community so it understands perfectly the issues surrounding improvements to radiotherapy.”
David Smith MBE is a Professional athlete, Coach, Speaker, and Writer who has faced and overcome adversity throughout his life and lives with a level of resilience that he hopes to inspire in others.
He writes a monthly column for The Herald newspaper in Scotland that has documented his journey and recent radiotherapy treatment.
Lord Turnberg FMed Sci is a leading clinic academic having held many distinguished senior positions including President of the Royal College of Physicians, Trustee of the Wolfson Foundation and Vice-president of the Academy of Medical Science. We are delighted that he has become a patron of Radiotherapy UK.
The late Lord Wade became life peer in the House of Lords in 1990 where he stayed until his retirement in 2016 and served as a member of the Science and Technology Select Committee.
Lord Wade was always interested in Radiotherapy, supporting the Wade Centre for Radiotherapy research, and helping to raise £25 million for Manchester’s Christie Hospital in a bid to revolutionise cancer treatment.
Lord Wade gave us advice and support in founding the charity and launching it in the House of Lords in 2010.
The late Lord Thomas was chief executive at co-op bank for 9 years before becoming a life peer in 1997, sitting in the House of Lords until 2016, where he was a member on the Monetary Policy and European Affairs Select Committees.
Lord Thomas gave us advice and support in founding the charity and launching it in the House of Lords in 2010.
© 2022 Radiotherapy UK.Registered as a charity in England and Wales. Charity number 1135902.
